Cargando…

Cellular phenotypic transitions in diabetic nephropathy: An update

Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yiling, Lin, Ji-Hong, Hammes, Hans-Peter, Zhang, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666367/ https://www.ncbi.nlm.nih.gov/pubmed/36408221 http://dx.doi.org/10.3389/fphar.2022.1038073

Ejemplares similares

Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy
por: Chang, Yun-peng, et al.
Publicado: (2017)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
por: Huang, Xin, et al.
Publicado: (2021)

Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
por: Xuan, Chen, et al.
Publicado: (2021)

The Protective Effect of Basic Fibroblast Growth Factor on Diabetic Nephropathy Through Remodeling Metabolic Phenotype and Suppressing Oxidative Stress in Mice
por: Wei, Tingting, et al.
Publicado: (2020)

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
por: Sugita, Erina, et al.
Publicado: (2021)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models
por: Wang, Qun, et al.
Publicado: (2022)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice
por: Zhu, Bingbing, et al.
Publicado: (2022)

miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression
por: Yang, Zijun, et al.
Publicado: (2018)

Interactions Among Non-Coding RNAs in Diabetic Nephropathy
por: Loganathan, Tamil Selvi, et al.
Publicado: (2020)

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy
por: Li, Wen, et al.
Publicado: (2021)

Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
por: Wang, Hong, et al.
Publicado: (2020)

Quercetin Attenuates Podocyte Apoptosis of Diabetic Nephropathy Through Targeting EGFR Signaling
por: Liu, Yiqi, et al.
Publicado: (2022)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
por: He, Yumei, et al.
Publicado: (2023)

Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
por: Lin, Wenwen, et al.
Publicado: (2022)

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy
por: Sabapathy, Vikram, et al.
Publicado: (2019)

ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
por: Shen, Yu-Li, et al.
Publicado: (2020)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy
por: Wu, Chenguang, et al.
Publicado: (2023)

Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies
por: Hu, Heng-Chang, et al.
Publicado: (2022)

Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
por: Shen, Yu-Li, et al.
Publicado: (2021)

Therapeutic effect and mechanism of combination therapy with ursolic acid and insulin on diabetic nephropathy in a type I diabetic rat model
por: Liu, Yang, et al.
Publicado: (2022)

Resveratrol Protects Against Post-Contrast Acute Kidney Injury in Rabbits With Diabetic Nephropathy
por: Wang, Yongfang, et al.
Publicado: (2019)

Cornus officinalis prior and post-processing: Regulatory effects on intestinal flora of diabetic nephropathy rats
por: Ju, Cheng-Guo, et al.
Publicado: (2022)

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
por: Sun, Meng-Yao, et al.
Publicado: (2019)

Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
por: Yi, Xinyao, et al.
Publicado: (2022)

Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

Cellular imaging: a key phenotypic screening strategy for predictive toxicology
por: Xu, Jinghai J.
Publicado: (2015)

The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis
por: Shen, Yuehong, et al.
Publicado: (2020)

Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
por: Zhao, Tingting, et al.
Publicado: (2022)

Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy
por: Fryer, Ryan M., et al.
Publicado: (2014)

The Effects of Rhubarb for the Treatment of Diabetic Nephropathy in Animals: A Systematic Review and Meta-analysis
por: Zeng, Jing-Yi, et al.
Publicado: (2021)

The role of Chinese herbal medicine in the treatment of diabetic nephropathy by regulating endoplasmic reticulum stress
por: Wei, Maoying, et al.
Publicado: (2023)

Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1
por: Lei, Chuntao, et al.
Publicado: (2022)

Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
por: Guo, Jenny Chun-Ling, et al.
Publicado: (2021)

Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
por: Murugavel, Shamini, et al.
Publicado: (2018)

Astragalus mongholicus Bunge and Panax notoginseng (Burkill) F.H. Chen Formula for Renal Injury in Diabetic Nephropathy—In Vivo and In Vitro Evidence for Autophagy Regulation
por: Wen, Dan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qlj7evj526p6b04g26chmccic